메뉴 건너뛰기




Volumn 125, Issue 4, 2010, Pages

Therapeutic strategy in p47-phox deficient chronic granulomatous disease presenting as inflammatory bowel disease

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ALEMTUZUMAB; AZATHIOPRINE; BUSULFAN; CYCLOSPORIN; FLUDARABINE; INFLIXIMAB; MESALAZINE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROTEIN P47; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STEROID; THALIDOMIDE;

EID: 77950359402     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2010.01.035     Document Type: Letter
Times cited : (39)

References (8)
  • 5
    • 34248342558 scopus 로고    scopus 로고
    • Chronic granulomatous disease (CGD) and complete myeloperoxidase deficiency both yield strongly reduced dihydrorhodamine 123 test signals but can be easily discerned in routine testing for CGD
    • Mauch L., Lun A., O'Gorman M.R., Harris J.S., Schulze I., Zychlinsky A., et al. Chronic granulomatous disease (CGD) and complete myeloperoxidase deficiency both yield strongly reduced dihydrorhodamine 123 test signals but can be easily discerned in routine testing for CGD. Clin Chem 53 (2007) 890-896
    • (2007) Clin Chem , vol.53 , pp. 890-896
    • Mauch, L.1    Lun, A.2    O'Gorman, M.R.3    Harris, J.S.4    Schulze, I.5    Zychlinsky, A.6
  • 6
    • 0034653483 scopus 로고    scopus 로고
    • Recombination events between the p47-phox gene and its highly homologous pseudogenes are the main cause of autosomal recessive chronic granulomatous disease
    • Roesler J., Curnutte J.T., Rae J., Barrett D., Patino P., Chanock S.J., et al. Recombination events between the p47-phox gene and its highly homologous pseudogenes are the main cause of autosomal recessive chronic granulomatous disease. Blood 95 (2000) 2150-2156
    • (2000) Blood , vol.95 , pp. 2150-2156
    • Roesler, J.1    Curnutte, J.T.2    Rae, J.3    Barrett, D.4    Patino, P.5    Chanock, S.J.6
  • 7
    • 0037114622 scopus 로고    scopus 로고
    • Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000
    • Seger R.A., Gungor T., Belohradsky B.H., Blanche S., Bordigoni P., Di B.P., et al. Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000. Blood 100 (2002) 4344-4350
    • (2002) Blood , vol.100 , pp. 4344-4350
    • Seger, R.A.1    Gungor, T.2    Belohradsky, B.H.3    Blanche, S.4    Bordigoni, P.5    Di, B.P.6
  • 8
    • 20544436474 scopus 로고    scopus 로고
    • Successful low toxicity hematopoietic stem cell transplantation for high-risk adult chronic granulomatous disease patients
    • Gungor T., Halter J., Klink A., Junge S., Stumpe K.D., Seger R., et al. Successful low toxicity hematopoietic stem cell transplantation for high-risk adult chronic granulomatous disease patients. Transplantation 79 (2005) 1596-1606
    • (2005) Transplantation , vol.79 , pp. 1596-1606
    • Gungor, T.1    Halter, J.2    Klink, A.3    Junge, S.4    Stumpe, K.D.5    Seger, R.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.